Abstract
Little is known about activated immune-inflammatory pathways and interleukin-6 (IL-6) in the development of fatigue and/or depression in patients with end-stage renal disease on chronic hemodialysis (HD).
Lingua originale | English |
---|---|
pagine (da-a) | 578-585 |
Numero di pagine | 8 |
Rivista | Journal of Pain and Symptom Management |
Volume | 49 |
DOI | |
Stato di pubblicazione | Pubblicato - 2015 |
Keywords
- Hemodialysis
- depression
- fatigue
- inflammation
- interleukin-6